<abstract xmlns="http://www.w3.org/1999/xhtml">

<bold>Background:</bold> Glioblastomas are the most common tumors of the central nervous system. The incidence of brain tumors is higher in developed countries and is constantly increasing.
<bold>Aim of the study:</bold> The purpose of this study was to analyze the clinicopathological data of patients diagnosed with glioblastomas from a selected case series.
<bold>Material and methods:</bold> This retrospective, single-center study was conducted on glioblastoma cases diagnosed between 2014 and 2018 at the Department of Pathology of the County Emergency Clinical Hospital of Târgu Mureș, Romania. The information was centralized from histopathology reports and focused on the location of glioblastomas and demographic parameters (gender and age of patients).
<bold>Results:</bold> In the studied period, there were 154 patients diagnosed with glioblastoma, of which 50.65% were men. The most affected age group was 61–70 years (31.17% of cases). In most cases (49.35%), the glioblastoma was located in the left cerebral hemisphere, and the most affected lobes were the frontal (29.87%), temporal (26.62%), and parietal (14.94%). We could not find a statistically significant association between the distribution of cases by years, gender, and location of the tumor.
<bold>Conclusions:</bold> Glioblastoma is a tumor that involves the left cerebral hemisphere most often and affects both genders over the age of sixty.
</abstract>

“George Emil Palade” University of Medicine, Pharmacy, Science and Technology

Study of Glioblastomas According to Clinicopathological Parameters

<abstract xmlns="http://www.w3.org/1999/xhtml">

<bold>Background:</bold> Gastritis is a progressive disease that evolves from a non-atrophic to an atrophic state and progresses through intestinal metaplasia, even leading to gastric cancer. Gastritis is defined by an inflammatory process of the mucosal lining of the stomach.
<bold>Aim:</bold> We aimed to identify any association between <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>)-positive gastritis and simple inflammatory markers derived from a complete blood count such as the platelet-to-lymphocyte ratio (PLR).
<bold>Material and Methods:</bold> We performed a retrospective case-control study in which we included patients who underwent an upper digestive endoscopy with biopsy between January 2019 and December 2020 and were diagnosed with gastritis. <italic>H. pylori</italic> status was determined from the histopathological examination, and complete blood count was performed from venous blood samples. The final study group included 125 patients with <italic>H. pylori</italic>-positive chronic gastritis, and the control group was made up by 207 patients without <italic>H. pylori</italic> infection.
<bold>Results:</bold> We found a higher value of the PLR in <italic>H. pylori</italic>-positive patients than in the control group, but the difference was not significant statistically.
<bold>Conclusions:</bold> PLR levels could be a predictor of inflammation in <italic>H. pylori</italic> infection, but an extensive study is needed to confirm this theory.
</abstract>

Department of Gastroenterology, Faculty of Medicine

A Link Between Platelet-to-Lymphocyte Ratio and <italic>Helicobacter pylori</italic> Infection

Severe Focal Stenosis of the Abdominal Aorta with High Risk of Occlusion

Is Periodontal Disease a Risk Factor for Recurrent Coronary Events?

<abstract xmlns="http://www.w3.org/1999/xhtml">

With increasing cases of fraud in submission, peer review, and publication processes, some by authors with fake identities and who use concocted emails, including the use of web-based emails, editors and publishers are looking for ways to try and stem the tide of fraud. In some journals, editors and publishers mistakenly believe that this might be possible by implementing a policy that mandates submitting authors to have an institutional email. However, this may be discriminatory at various levels, the most obvious of which is unfairness, i.e., no right to “entry” to a journal based exclusively on the type of email used, even more so when the submitting author is not fake. Such policies might, very ironically, even violate stated journal or publisher policies on discrimination and inclusivity. Editors and publishers that employ such tactics, as a way to attempt to reduce fraudulent submissions, need to rethink this potentially discriminatory strategy. In a publishing world that is becoming increasingly litigious, it would not be surprising if legal action would one day be taken against a journal or publisher by a valid author using a web-based email such as @gmail.com, @yahoo.com, or @163.com, but who may have been unfairly barred entry to that journal based on such a policy. Two real case examples are provided, <italic>Tumor Biology</italic>, a struggling journal published by IOS Press, and <italic>Journal of Business Ethics</italic>, a journal published by Springer Nature.
</abstract>

Are Mandatory Institutional Emails for Manuscript Submission an Unfair and Discriminatory Policy?

AHEAD OF PRINT

Volume 8 (2023): Issue 3 (September 2023)

Volume 8 (2023): Issue 2 (June 2023)

Volume 8 (2023): Issue 1 (March 2023)

Volume 7 (2022): Issue 4 (December 2022)

Volume 7 (2022): Issue 3 (September 2022)

Volume 7 (2022): Issue 2 (June 2022)

Volume 7 (2022): Issue 1 (March 2022)

Volume 6 (2021): Issue 4 (December 2021)

Volume 6 (2021): Issue 3 (September 2021)

Volume 6 (2021): Issue 2 (June 2021)

Volume 6 (2021): Issue 1 (March 2021)

Volume 5 (2020): Issue 4 (December 2020)

Volume 5 (2020): Issue 3 (September 2020)

Volume 5 (2020): Issue 2 (June 2020)

Volume 5 (2020): Issue 1 (March 2020)

Volume 4 (2019): Issue 4 (December 2019)

Volume 4 (2019): Issue 3 (September 2019)

Volume 4 (2019): Issue 2 (June 2019)

Volume 4 (2019): Issue 1 (March 2019)

Volume 3 (2018): Issue 4 (December 2018)

Volume 3 (2018): Issue 3 (September 2018)

Volume 3 (2018): Issue 2 (June 2018)

Volume 3 (2018): Issue 1 (March 2018)

Volume 2 (2017): Issue 4 (December 2017)

Volume 2 (2017): Issue 2 (June 2017)

Volume 2 (2017): Issue s4 (December 2017)

Volume 2 (2017): Issue s3 (May 2017)

Volume 2 (2017): Issue 3 (September 2017)

Volume 2 (2017): Issue s1 (March 2017)

Volume 1 (2016): Issue 3 (December 2016)

Volume 1 (2016): Issue 2 (September 2016)

Volume 1 (2016): Issue 1 (June 2016)

Volume 1 (2016): Issue s2 (November 2016) Special Issue

Journal of Interdisciplinary Medicine

 The Journal of Interdisciplinary Medicine aims to publish top quality papers related to any fields of medicine that present an interdisciplinary dimension.  The journal will mainly focus on recent advances in the field of diagnosis and treatment of the most common situations encountered in the clinical or research practice. Interdisciplinary approaches will be extremely welcomed, presenting new advances in the approach of different pathologies from the perspective of various clinical fields.  The Journal of Interdisciplinary Medicine will publish high-quality basic and clinical research related to interdisciplinary medical fields, in a common approach that will integrate the clinical studies with the pre-clinical work dedicated to discovery of new mechanisms involved in the development and progression of a large spectrum of diseases.  The journal will try to provide the entire medical community with the perspective of the regional specifics in Central and Eastern European countries. The journal will primarily focus on publishing original research papers, but also other types of materials (such as review articles, case reports, state of the art papers, comments to editor, etc) will be extremely welcomed.  Rejection Rate:   30%   Archiving  Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.  Plagiarism Policy  The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. 

Journal of Interdisciplinary Medicine

Volume 6 (2021): Issue 4 (December 2021)

Study of Glioblastomas According to Clinicopathological Parameters

A Link Between Platelet-to-Lymphocyte Ratio and Helicobacter pylori Infection

Severe Focal Stenosis of the Abdominal Aorta with High Risk of Occlusion

Is Periodontal Disease a Risk Factor for Recurrent Coronary Events?

Are Mandatory Institutional Emails for Manuscript Submission an Unfair and Discriminatory Policy?

Search

All Volumes and Issues in this Journal